Anne Kirsti Blystad

High-Dose Therapy and Autologous Stem-Cell Support for Chemosensitive Transformed Low-Grade Follicular Non-Hodgkin’s Lymphoma: A Case-Matched Study From the European Bone Marrow Transplant Registry

C. D. Williams, Claire Harrison, T. Lister et al. · Journal of Clinical Oncology · 2001 · 130 citations

Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens

Sigbjørn Smeland, Anne Kirsti Blystad, Stein Kvaløy et al. · Annals of Oncology · 2004 · 83 citations

Lymphoid Neoplasia, 20-Year Experience, Norwegian Radium Hospital +3

Expression of bcl-6 and CD10 Protein Is Associated With Longer Overall Survival and Time to Treatment Failure in Follicular Lymphoma

Nurija Bilalović, Anne Kirsti Blystad, Rastko Golouh et al. · American Journal of Clinical Pathology · 2004 · 56 citations · Full text

Immunology, Pathology, Cd10+ Fls +16

Infused CD34⁺ cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B‐cell lymphoma and follicular lymphoma grade 3 treated with high‐dose therapy

Anne Kirsti Blystad, Jan Delabie, Stein Kvaløy et al. · British Journal of Haematology · 2004 · 56 citations · Full text

A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non‐Hodgkin lymphoma

Knut B. Smeland, Cecilie E. Kiserud, Grete F. Lauritzsen et al. · British Journal of Haematology · 2016 · 30 citations · Full text